Publication | Closed Access
Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells
837
Citations
36
References
2007
Year
Hematological MalignancyOncologyMedicineCd11b+gr1+ Myeloid CellsMyeloid NeoplasiaImmune Checkpoint InhibitorRadiation OncologyCancer BiologyCell BiologyCancer ResearchTumor BiologyAnti-vegf TreatmentTumor Refractoriness
| Year | Citations | |
|---|---|---|
Page 1
Page 1